PD45 Paying For Digital Health: What Evidence Is Needed?

Introduction Digital transformation has been promoted by the World Health Organization (WHO), Food and Drug Administration (FDA) European Commission (EC) to help improve health outcomes. To ensure sustainability, digital interventions (DHI) require funding payers. Evidence-informed decision policy making requires an assessment of impact on relevant outcomes vs current healthcare practice. Various national international organizations are involved in creating or guiding development standards for evidence required technologies. Methods We undertook intensive individual investigation websites leading payer technology (HTA) bodies France, UK, Germany, Belgium, Austria, Finland, Canada, Australia, USA identify new frameworks any updated information. As objective focused evaluation which were used across DHIs a particular support pricing reimbursement decisions, we excluded case studies where had assessed, regulatory approval assessed feasibility applicability DHI since these not directly influencing funding. Results found six address purposes reimbursement: NICE Evidence Standards, FinCCHTA, MSAC, Germany BfArM, Belgium RIZIV France HAS. The context framework requirements compared parameters including those normally HTA criteria related included varied considerably as did level expected be available assessment. In some cases, risk intended DHI. Conclusions While increasingly health, is struggling adapt assess Due multidisciplinary nature (combination care technology), speed rate change innovations this area, approach based upon posed seems reasonable. way effort can tailored seek influence predict rather than increased awareness patient about their condition.